Exact Mass: 383.04952140000006
Exact Mass Matches: 383.04952140000006
Found 23 metabolites which its exact mass value is equals to given mass value 383.04952140000006,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-(S-Glutathionyl)acetyl chloride
C12H18ClN3O7S (383.05539480000004)
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
S-(2-Chloroacetyl)glutathione
C12H18ClN3O7S (383.05539480000004)
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
3-{[(1s)-2,2-Difluoro-1-Hydroxy-7-(Methylsulfonyl)-2,3-Dihydro-1h-Inden-4-Yl]oxy}-5-Fluorobenzonitrile
C17H12F3NO4S (383.04391080000005)
Belzutifan
C17H12F3NO4S (383.04391080000005)
ethyl 2-[(2-chloroacetyl)amino]-4-(3,4-dimethoxyphenyl)thiophene-3-carboxylate
C17H18ClNO5S (383.05941680000006)
5-Chloro-3-ethyl-2-methylbenzothiazolium p-toluenesulfonate
Belzutifan
C17H12F3NO4S (383.04391080000005)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents Belzutifan (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. Belzutifan, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. Belzutifan is a potential treatment for clear cell renal cell carcinoma (ccRCC)[1].
5-Methylaminomethyl-2-thiouridine 5-monophosphate
C11H18N3O8PS (383.05521980000003)
3-{[(1s)-2,2-Difluoro-1-Hydroxy-7-(Methylsulfonyl)-2,3-Dihydro-1h-Inden-4-Yl]oxy}-5-Fluorobenzonitrile
C17H12F3NO4S (383.04391080000005)
[(1R)-1-[(7S)-2-amino-7-methyl-4-oxo-7,8-dihydro-3H-pteridin-6-yl]ethyl] phosphono hydrogen phosphate
4,9,14-triamino-1,2,11,12-tetraoxa-6,7-dithiacycloheptadecane-3,10,13,17-tetrone
6-[[(4-Chlorophenyl)thio]methyl]-2-phenyl-1,7-dihydropyrazolo[3,4-b]pyridine-3,4-dione
C19H14ClN3O2S (383.04952140000006)
3-(2-chlorophenyl)-N-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-5-methyl-4-isoxazolecarboxamide
C19H14ClN3O2S (383.04952140000006)
2-(4-chlorophenoxy)-N-(2-thiophen-2-yl-3-imidazo[1,2-a]pyridinyl)acetamide
C19H14ClN3O2S (383.04952140000006)
2-(S-Glutathionyl)acetyl chloride
C12H18ClN3O7S (383.05539480000004)
PT-2385
C17H12F3NO4S (383.04391080000005)
PT-2385 is a selective HIF-2α inhibitor with a Ki of less than 50 nM[1][2].